Tuesday, May 7
8 a.m. - 12 p.m.
Workshop
AAV Manufacturing for CMC Success: Translating Preclinical Gene Therapy Products to Clinical Success
1:30 p.m. - 3:15 p.m.
Oral Abstract Sessions
AAV Vectors - Preclinical and Proof-of-Concept Therapy Focus
AAV Vectors - Product Development, Manufacturing, and Approval Considerations Session 1
Wednesday, May 8
8 a.m. - 9:45 a.m.
Scientific Symposium
Prospects for Prenatal Gene and Cell Therapy
1:30 p.m. - 3:15 p.m.
Oral Abstract Sessions
AAV Vectors - Product Development, Manufacturing, and Approval Considerations Session 2
AAV Vectors - Virology and Vectorology Session 1
3:45 p.m. - 5:30 p.m.
AAV Vectors - Product Development, Manufacturing, and Approval Considerations Session 3
Oral Abstract Session
AAV Vectors - Capsid Engineering Session 1
Thursday, May 9
8 a.m. - 9:45 a.m.
Scientific Symposium
Searching for Goldilocks – Scaling for AAV Clinical Dose Prediction
1:30 p.m. - 3:15 p.m.
Oral Abstract Session
New Avenues for Viral Vectors
3:45 p.m. - 5:30 p.m.
Oral Abstract Sessions
Emerging Viral Vectors
AAV Vectors - Capsid Engineering for Muscles
Friday, May 10
8 a.m. - 9:45 a.m.
Oral Abstract Session
Late-Breaking Abstracts Session 2
1:30 p.m. - 3:15 p.m.
Oral Abstract Sessions
AAV Vectors - Preclinical and Proof-of-Concept Technology Focus
AAV Vector Biology and Development Session 2
3:45 p.m. - 5:30 p.m.
Oral Abstract Sessions
AAV Vectors - Product Development, Manufacturing, and Approval Considerations Session 4
AAV Vectors - Non-Human Primates and Large Animal Models
AAV Vectors - Capsid Engineering for Tissue-Specific Targeting
Saturday, May 11
8 a.m. - 9:45 a.m.
Oral Abstract Session
AAV Vectors - Immune Modulation
Scientific Symposia
Recent Advancements that Expand Viral Vector Delivery Applications
Companion Diagnostics for AAV-based Gene Therapies
10:15 a.m. - 12 p.m.
Oral Abstract Session
AAV Vectors - Product Development, Manufacturing, and Approval Considerations Session 5
Vector Product Engineering, Development, and Manufacturing (excluding AAV)